Medical technology continues to lead other fields in terms of commercialization, as medical technology innovators remained at the top of the European Patent Office's patent protection rankings last year. 

Thomas Prock

The recent publication of the European Patent Office’s Annual Report shows that medical technology continues to lead other fields in terms of commercialization, as medical technology innovators remained at the top of the patent protection rankings last year. In 2016, more European patent applications were filed for medical technology than for any other type of technology, including digital communication, biotechnology, and pharmaceuticals. Medical technology has led the pack since 2007, when it first overtook computer technology as the field with most...

March 28th, 2017
0

Not paying down technical debt in a timely fashion can bankrupt your product.

Andrew Dallas

Often during the research phase of medical technology or device development, software is more of an evolved entity than a well-designed one. Later, during commercial development, time and budget may lead to re-use of that software as well as taking shortcuts in the implementation rather than coding “the right way.” The accumulation of these compromises is known as technical debt. Technical debt has a tangible financial cost to the product throughout its life cycle. If the technical debt isn’t “paid off” judiciously, it can bankrupt a product.

...
March 27th, 2017
0

Find out which medtech companies advanced to the next round of our startup tournament. It's time for you to weigh in again!

Marie Thibault

Our Medtech Startup Showdown is underway and readers have voted for their favorites companies from Round 1 of the tournament. Now, it's time for Round 2!

This week, these eight remaining companies will face off against each other: Applied Nanoscience Inc., Linear Health Sciences, PAVmed Inc., Acutus Medical, Admetsys, NeoLight, MedicusTek USA Corporation, and UVision 360.

Round 2 voting will be open until end of day on Sunday, April 2. Round 3 will...

March 27th, 2017
0
 

Applied Nanoscience Inc.

vs.

Linear Health Sciences

 

 

Describe your device and how it will benefit healthcare.

 

 

 

 

 ...

March 27th, 2017
0
 

PAVmed Inc.

vs.

Acutus Medical

 

 

 

Describe your device and how it will benefit healthcare.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 ...

March 27th, 2017
0
 

Admetsys

vs.

NeoLight

 

 

 

Describe your device and how it will benefit healthcare.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

...
March 27th, 2017
0
 

MedicusTek USA Corp.

vs.

UVision 360

 

 

 

Describe your device and how it will benefit healthcare.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

...
March 27th, 2017
0

A look at the current patent landscape in the field of robotic-assisted surgery, a rapidly growing area of medical technology.

David Cohen, PhD

The field of robotic-assisted surgery is growing as companies like TransEnterix and Zimmer Biomet develop offerings.

Patents directed toward robotic devices and systems that assist in surgical procedures began to appear about 30 years ago, filed by companies like Computer Motion, IBM, Ichikoh Industries, and others. A current overview of the robotic surgical space shows there are about 100 companies, universities, and research institutes that own more than 1000 issued U.S....

March 26th, 2017
0

This primer will help medical device manufacturers that are already familiar with RoHS gain a better understanding of the European Chemical Agency’s REACH legislation.

Nigel Syrotuck

The Importance of Understanding REACH

In February 2017, the European Chemical Agency (ECHA) released a draft guidance on requirements for substances in articles under REACH (Registration, Evaluation, Authorization, Restriction of Chemicals, Regulation (EC) No 1907/2006). REACH is an extremely important (and complex) piece of legislation to understand, but just like RoHS (Restriction of the use of certain Hazardous Substances, Directive 2011/65/E), meeting its requirements is a must to sell products in Europe....

March 23rd, 2017
0

Material selection for medical devices is of critical importance for reducing risk of a failure and hinges on many factors.

Jeff Ellis, PhD

Medical device material failures are common and costly. Fortunately, the risk of these failures can be greatly reduced through better understanding of materials science earlier in the product development cycle, preventing both delays and postmarket issues.

Using data found on the FDA website, our team of researchers concluded that materials were either a major or possible cause of more than 30 percent of medical device FDA recalls in 2013 and 2014. Whether they incite FDA recalls or development setbacks, many of these material failures can be avoided by gaining a better understanding of the materials’ properties and...

March 22nd, 2017
0